---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-149094"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2021-12-13T23:59:59+00:00"
generated_at: "2026-06-28T01:47:22.350473+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Abbott director Roxanne S. Austin will not stand for re-election in 2022

## Summary
- Roxanne S. Austin informed Abbott Labs board on Dec 9, 2021 of her decision not to seek re-election.
- Her current term ends at the April 2022 annual shareholders meeting.
- She will step down at that time; no replacement or reason specified in filing.

## SEC filing metadata
- accession: 0001104659-21-149094
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2021-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465921149094/0001104659-21-149094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465921149094/tm2135223d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-149094
- JSON: https://secwatch.observer/filing/0001104659-21-149094.json
- Plain text: https://secwatch.observer/filing/0001104659-21-149094.txt

## Key facts
- Executive change
  Roxanne S. Austin departed as Director at ABBOTT LABORATORIES.
  - Action: not standing for re-election
  - Role: Director
  source text: On December 9, 2021, Roxanne S. Austin informed the Abbott Laboratories Board of Directors of her decision not to stand for re-election at the end of her current term expiring at the 2022 annual shareholders meeting in April.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800/000110465921149094/0001104659-21-149094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.